UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era

Breast (Edinburgh), 2021-12, Vol.60, p.15-25

2021

Volltextzugriff (PDF)

A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets

Journal of hepatology, 2019-07, Vol.71 (1), p.78-90

2019

Volltextzugriff (PDF)

Targeting hyaluronan metabolism-related molecules associated with resistant tumor-initiating cells potentiates chemotherapy efficacy in lung cancer

Scientific reports, 2024-07, Vol.14 (1), p.16803-14, Article 16803

2024

Volltextzugriff (PDF)

Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins

Clinical cancer research, 2014-11, Vol.20 (22), p.5697-5707

2014

Volltextzugriff (PDF)

Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features

Current treatment options in oncology, 2023-11, Vol.24 (11), p.1550-1567

2023

Volltextzugriff (PDF)

Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experience

Endocrine, 2023-04, Vol.80 (1), p.134-141

2023

Volltextzugriff (PDF)

Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients

Cancer Immunology, Immunotherapy, 2023-08, Vol.72 (8), p.2687-2700

2023

Volltextzugriff (PDF)

Detection of NTRK gene fusions in solid tumors: recommendations from a Latin American group of oncologists and pathologists

Future oncology (London, England), 2023-12, Vol.19 (40), p.2669-2682

2023

Volltextzugriff (PDF)

4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis

Glycobiology (Oxford), 2015-08, Vol.25 (8), p.825-835

2015

Volltextzugriff (PDF)

Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice

Stem cells and development, 2015-03, Vol.24 (6), p.791

2015

Volltextzugriff (PDF)

Ex vivo loading of autologous dendritic cells with tumor antigens

Methods in molecular biology (Clifton, N.J.), 2014, Vol.1139, p.41

2014

Volltextzugriff (PDF)

Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma

PloS one, 2014-04, Vol.9 (4), p.e95171-e95171

2014

Volltextzugriff (PDF)

Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice

Glycobiology (Oxford), 2012-03, Vol.22 (3), p.400-410

2012

Volltextzugriff (PDF)

Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients

Cancer Immunology, Immunotherapy, 2019-10, Vol.68 (10), p.1585-1596

2019

Volltextzugriff (PDF)

EGFR-Tyrosine Kinase Inhibitor Retreatment in Non-Small-Cell Lung Cancer Patients Previously Exposed to EGFR-TKI: A Systematic Review and Meta-Analysis

Journal of personalized medicine, 2024-07, Vol.14 (7), p.752

2024

Volltextzugriff (PDF)

Pulsing dendritic cells with whole tumor cell lysates

Methods in molecular biology (Clifton, N.J.), 2014, Vol.1139, p.27

2014

Volltextzugriff (PDF)

P2.12: Treatment Response in Patients With ALK Immunohistochemistry (IHC) Positive With Fish Negative: Track: Pathology

Journal of thoracic oncology, 2016-10, Vol.11 (10), p.S223-S223

2016

Volltextzugriff (PDF)

P2.38: Nivolumab in Clinical Practice: Real World Experience in an Argentina Oncologic Center: Track: Immunotherapy

Journal of thoracic oncology, 2016-10, Vol.11 (10), p.S240-S241

2016

Volltextzugriff (PDF)

Hepatocellular Carcinoma Cells and Their Fibrotic Microenvironment Modulate Bone Marrow-Derived Mesenchymal Stromal Cell Migration in Vitro and in Vivo

Molecular pharmaceutics, 2011-10, Vol.8 (5), p.1538-1548

2011

Volltextzugriff (PDF)

Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting

International journal of clinical oncology, 2021-06, Vol.26 (6), p.1057-1064

2021

Volltextzugriff (PDF)

Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database

JCO global oncology, 2020-04, Vol.6 (6), p.639-646

2020

Volltextzugriff (PDF)

Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction

PloS one, 2014-09, Vol.9 (9), p.e107944-e107944

2014

Volltextzugriff (PDF)

Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells

International journal of cancer, 2010-06, Vol.126 (11), p.2726-2740

2010

Volltextzugriff (PDF)

Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization

Cancer chemotherapy and pharmacology, 2011-03, Vol.67 (3), p.723-728

2011

Volltextzugriff (PDF)

Retreatment with EGFR inhibitor in non-small cell lung cancer patients previously exposed to EGFR-TKI: A systematic review and meta-analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21159-e21159

2023

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(28)
Oncology
(19)
Humans
(17)
Male
(11)
Animals
(10)
Cell Line, Tumor
(10)
Immunotherapy
(9)
Mice
(9)
Tumors
(8)
Medicine
(7)
Medicine & Public Health
(7)
Cancer Therapies
(6)
Carcinoma, Hepatocellular - Pathology
(6)
Chemotherapy
(6)
Lung Cancer
(6)
Antineoplastic Agents - Pharmacology
(5)
Cancer Research
(5)
Cell Movement - Drug Effects
(5)
Female
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era

A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets

Targeting hyaluronan metabolism-related molecules associated with resistant tumor-initiating cells potentiates chemotherapy efficacy in lung cancer

Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins

Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features

Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experience

Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients

Detection of NTRK gene fusions in solid tumors: recommendations from a Latin American group of oncologists and pathologists

4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis

Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice

Ex vivo loading of autologous dendritic cells with tumor antigens

Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma

Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice

Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients

EGFR-Tyrosine Kinase Inhibitor Retreatment in Non-Small-Cell Lung Cancer Patients Previously Exposed to EGFR-TKI: A Systematic Review and Meta-Analysis

Pulsing dendritic cells with whole tumor cell lysates

P2.12: Treatment Response in Patients With ALK Immunohistochemistry (IHC) Positive With Fish Negative: Track: Pathology

P2.38: Nivolumab in Clinical Practice: Real World Experience in an Argentina Oncologic Center: Track: Immunotherapy

Hepatocellular Carcinoma Cells and Their Fibrotic Microenvironment Modulate Bone Marrow-Derived Mesenchymal Stromal Cell Migration in Vitro and in Vivo

Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting

Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database

Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction

Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells

Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization

Retreatment with EGFR inhibitor in non-small cell lung cancer patients previously exposed to EGFR-TKI: A systematic review and meta-analysis

Suchergebnisse filtern